Prothionamide: Clinical Trials

2 trials of Prothionamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Completed 1

Follow Prothionamide: new trials by email Literature Review of Prothionamide trials Research Report on Prothionamide

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort
Bedaquiline, Delamanid, Contezolid - Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
Phase 3Active not recruitingBeijing Chest Hospital1862023-12-222025-04-01
The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB
Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine - MDR-TB
Phase 3CompletedIUATLD, Inc5882016-03-012023-09-28

Conditions studied

Tuberculosis (1)  ·  Tuberculosis, Multidrug-Resistant (1)  ·  Tuberculosis, Pulmonary (1)

Sponsors

Beijing Chest Hospital (1)  ·  IUATLD, Inc (1)

Countries

China (1)  ·  Ethiopia (1)  ·  Georgia (1)  ·  India (1)  ·  Moldova (1)  ·  Mongolia (1)  ·  South Africa (1)  ·  Uganda (1)

Top investigators

Andrew Nunn, PhD (1)  ·  Sarah Meredith, MD (1)

Results publications

PMID 26929418, PMID 30865791, PMID 38462751